Journal profile
Journal de la Faculte de Medecine dOran
ISSN 2571-9874 · eISSN 2602-6511 · University of Oran 1 · Algeria
Journal de la Faculte de Medecine dOran: diamond open access (no APC); no APC; review about 23 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
Journal de la Faculte de Medecine dOran is published by University of Oran 1. By OpenAlex counts of its recent articles, its largest topics are Genetic Associations and Epidemiology, Diabetes Management and Research and Epilepsy research and treatment, together about 21.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Oran Faculty of Medicine (JFMO) is addressed to all health actors in a multidisciplinary perspective (Medicine, Pharmacy, Dental Medicine, Basic Sciences, and Social Sciences). Its objectives are to introduce researchers to scientific writing in order to ensure better visibility of their research work. Its mission is to support research in the health sciences, to promote the sharing of knowledge between researchers and practitioners in the field, and to facilitate the exchange of practices between professionals. The Journal of Oran Faculty of Medicine is half-yearly. It publishes scientific articles such as Editorials, Original Articles, Systematic Reviews, Updates, Clinical Cases, Methodological Notes and "Read for you". It also publishes letters in response to the Journal articles in the Correspondence Section. Publications are in French or English. They must comply with the instructions below. These are derived from the manuscript submission standards, proposed by the International Committee of Medical Journal Editors, known as the Vancouver Group (ICMJE) (www.icmje.org). You can view this journal's website here.
From the journal's Aims & Scope
Editor-in-chief Abdelmadjid SNOUBERPublisher website
Editorial board by country: none in mainland China; most named Algeria 20, France 3, Egypt 1, Iraq 1, Tunisia 1 (27 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology7.6%
- Diabetes Management and ResearchMedicine7.6%
- Epilepsy research and treatmentMedicine6.3%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology5.1%
- Nanoparticle-Based Drug DeliveryMaterials Science3.8%
- Innovations in Medical EducationMedicine3.8%
- Congenital Heart Disease StudiesMedicine3.8%
- Hematopoietic Stem Cell TransplantationMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ASJPPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 2OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 140 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 4 |
| 2025 | 0 | 0 | 8 |
| 2024 | 0 | 0 | 5 |
| 2023 | 16 | 16 | 4 |
| 2022 | 14 | 14 | 4 |
| 2021 | 17 | 17 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 23 weeksLetPub ·
- Submission to publication (journal-reported)
- about 23 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Reference style
- Vancouver
Article types accepted5, with length limits
- clinical case and brief communicationClinical case and brief communication: (1.000 to 1.500 words, 10 references maximum, summary in French and English).references ≤ 10
- editorialfer according to the type of article: - Editorial (1.500 words, 5 references, no summary). The editorial can draw attentiomain text ≤ 1,500 words · references ≤ 5
- research articleResearch article (2.000 to 3.000 words, at least 30 references, summary in French and English).references ≤ 30
- systematic reviewstarts with a summary of the results. - Systematic Review (5.000 words, 80 references maximum, summary in French and English). Thimain text ≤ 5,000 words · references ≤ 80
- updateUpdate: (2.500 words, 50 references maximum, summary in French and English).references ≤ 50
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- AI use
Generative AI usage confined to enhancing readability and language, with human oversight; AI cannot be credited as author. Model summary
In instances where authors employ generative artificial intelligence (AI) and AI-assisted technologies during the writing stage, their usage should be confined to enhancing readability and language. Implementation of such technology must be accompanied by human oversight and control.
Source ↗Publisher website ·- Authorship Authorship and Originality:
All submissions must be original work and must not be under consideration for publication elsewhere. Proper acknowledgment of the work of others should be provided. All authors should have made substantial contributions to: - the conception and design of the study, acquisition of data, or analysis and interpretation of data. - drafting the article.. - final approval before submission of the articl…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest:
Authors, editors, and reviewers must disclose any conflicts of interest that could influence the evaluation process.
Source ↗Publisher website ·- Data availability Data Access and Retention:
Authors may be required to provide access to raw data; data should be retained for a reasonable period after publication. Model summary
Authors may be required to provide access to raw data if requested by the editorial team. Authors should retain data for a reasonable period after publication.
Source ↗Publisher website ·- Publication ethics
Compliance with Declaration of Helsinki ethical recommendations. Model summary
The submitted work must comply with current laws on biomedical experimentation and the ethical recommendations of the Declaration of Helsinki ("WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects").
Source ↗Publisher website ·- License & copyright Copyright Notice
Copyright owned by the Journal; published under CC BY-NC 4.0. Model summary
The Journal owns the copyright to the journal content. This work is published under a Creative Commons Attribution-NonCommercial 4.0 International License. E-ISSN: 2602-6511Print ISSN: 2571-9874
Source ↗Publisher website ·- Open access Open Access Policy
Immediate open access Model summary
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Open access journal licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Source ↗Publisher website ·- Peer review Peer Review Process:
Double-blind peer review process facilitated through the ASJP Governmental platform. Model summary
JFMO employs a transparent and unbiased double-blind peer review process, facilitated through the ASJP Governmental platform, to ensure the quality and integrity of published articles. Reviewers and authors are not aware of each other's identities during the review process, ensuring an impartial evaluation.
Source ↗Publisher website ·- Plagiarism Plagiarism and Citation:
Written permission from copyright holders required for copyrighted material; precautions to avoid plagiarism. Model summary
Plagiarism in any form is strictly prohibited. Proper citation and referencing should be provided for all sources. Plagiarism in the context of article publication refers to the act of presenting someone else's ideas, words, or work as one's own without proper attribution or permission. It involves the unauthorized use or reproduction of another author's intellectual property, including text, idea…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- University of Oran 1
- Country or region
- Algeria
- Language
- English, French
- ISSN
- 2571-9874
- Electronic ISSN
- 2602-6511
- Latest issue on the website
- Volume 10, Issue 01 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal de la Faculte de Medecine dOran
How long does peer review take at Journal de la Faculte de Medecine dOran?
Authors report an average review time of about 23 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal de la Faculte de Medecine dOran based?
Of the 27 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Algeria (20), France (3) and Egypt (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal de la Faculte de Medecine dOran?
According to LetPub and DOAJ records, Journal de la Faculte de Medecine dOran is indexed in DOAJ.
Is Journal de la Faculte de Medecine dOran open access, and what is the APC?
Journal de la Faculte de Medecine dOran is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .